Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Our Donors
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Peripheral immune signatures of neurodegeneration in isolated REM sleep behavior disorder: an MRI-neuroinflammation study

Project Overview

When we dream, our bodies are normally paralyzed so we don’t act out the dream. In isolated REM sleep behavior disorder (iRBD), that safety switch fails: people may talk, shout, punch, or kick during sleep. iRBD is important because most people with it will later develop a brain disease like Parkinson’s disease or dementia with Lewy bodies. This gives us a rare “early warning” stage when help may make the biggest difference.

Our project asks a simple question with big implications: do signs of inflammation in the blood line up with early changes we can see on brain scans in people with iRBD? If they do, a routine blood test might inform on brain neurodegeneration and guide prevention trials.

We will study iRBD volunteers from the long-running Montreal iRBD cohort. First, we will analyze blood plasma for a high-throughput test that measures over a thousand proteins tied to immune and inflammatory pathways. We will profile immune cells at single-cell resolution and read their T-cell receptors to see which cell types and immune “programs” are active. At the same time, we will use MRI to measure three sensitive signs of early brain injury: extra water around brain cells (“free water”), shrinkage of vulnerable regions, and a fluid-clearance measure that reflects how well the brain removes waste. Using robust statistical tools, we will then look for patterns (which blood signals go with which brain changes?) and then test whether those patterns relate to clinical changes.

This work unites specialists in brain imaging, blood-based inflammation assays and immune cell profiling, and clinical leadership. In the short term, we aim to deliver clear blood-brain signatures of risk in iRBD. In the longer term, these findings could help identify who needs closer follow-up, select people for preventive trials, and point to novel targets for treatments.

Principal Investigator

Shady Rahayel , Université de Montréal

Team Members

Jo Anne Stratton, Montreal Neurological Institute, McGill University

Martine Tetreault, University of Montreal

Ronald Postuma, McGill University

Christina Tremblay, CIUSSS-du-Nord-de-l’Ile-de-Montreal

Veronique Daneault, CIUSSS-du-Nord-de-l’Ile-de-Montreal

Alexandre Pastor-Bernier, CIUSSS-du-Nord-de-l’Ile-de-Montreal

Partners and Donors

Krembil Foundation

Project Ongoing

Peripheral immune signatures of neurodegeneration in isolated REM sleep behavior disorder: an MRI-neuroinflammation study

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Parkinson's

  • Competition

    Accelerator Grants: Neurodegeneration x Immunology

  • Province

    Québec

  • Start Date

    2026

  • Total Grant Amount

    $300,000

  • Health Canada Contribution

    $150,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2026 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co